Developmental neurotoxicity – Challenges in the 21st Century and In Vitro Opportunities
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
In recent years neurodevelopmental problems in children have increased at a rate that suggests lifestyle factors and chemical exposures as likely contributors. When environmental chemicals contribute to neurodevelopmental disorders developmental neurotoxicity (DNT) becomes an enormous concern. But how can it be tackled? Current animal test- based guidelines are prohibitively expensive, at $ 1.4 million per substance, while their predictivity for human health effects may be limited, and mechanistic data that would help species extrapolation are not available. A broader screening for substances of concern requires a reliable testing strategy, applicable to larger numbers of substances, and sufficiently predictive to warrant further testing. This review discusses the evidence for possible contributions of environmental chemicals to DNT, limitations of the current test paradigm, emerging concepts and technologies pertinent to in vitro DNT testing and assay evaluation, as well as the prospect of a paradigm shift based on 21st century technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
miRBase: integrating microRNA annotation and deep-sequencing data
Kozomara, A., & Griffiths-Jones, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1027 · Cited by 3,634
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817 · cited 1×
“3D cell culture clearly improves the physiological relevance of cell-based assays and the comparability between in vitro cultures and living organisms (Pampaloni et al., 2007).”
Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
Developmental neurotoxicity of industrial chemicals
Grandjean, P., & Landrigan, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69665-7 · Cited by 1,984
Neurobehavioural effects of developmental toxicity
Grandjean, P., & Landrigan, P. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70278-3 · Cited by 1,886
Five steps to conducting a systematic review
Khan, K. S., Kunz, R., Kleijnen, J., & Antes, G. (2003) · Journal of the Royal Society of Medicine · doi:10.1177/014107680309600304 · Cited by 1,873 · cited 1×
“this is in contrast to the animal model, which can only provide limited mechanistic information because of its complexity, limited tulated Pot and biomarkers from the literature in general and for known developmental neurotoxicants: framing the questions to be addressed, identifying the scope of relevant work, judging…”
ResultIlluminating the silence: understanding the structure and function of small RNAs
Rana, T. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2085 · Cited by 1,083
Regulation of miRNA expression during neural cell specification
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03978.x · Cited by 707
Self-citationWhat causes autism? Exploring the environmental contribution
Landrigan, P. J. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328336eb9a · Cited by 429 · cited 4×
“Altex 31, 2/14 141 mental disorders in children (Kuehn, 2010; Sagiv et al., 2010; Grandjean and landrigan, 2006; landrigan, 2010).”
BackgroundInfluentialPotential developmental neurotoxicity of pesticides used in Europe
Bjørling-Poulsen, M., Andersen, H. R., & Grandjean, P. (2008) · Environmental Health · doi:10.1186/1476-069x-7-50 · Cited by 407
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371
A Modular Approach to the ECVAM Principles on Test Validity
Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., et al. (2004) · Alternatives to Laboratory Animals · doi:10.1177/026119290403200503 · Cited by 341 · cited 1×
“the formal validation of in vitro tests (Hartung et al., 2004; Hartung, 2007a; leist et al., 2012) has established a path for providing the evidence that non-animal tests can be used without compromising patient and consumer health.”
BackgroundSelf-citationCytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314
Differential monocyte responses to TLR ligands in children with autism spectrum disorders
Enstrom, A. M., Onore, C. E., Van de Water, J. A., & Ashwood, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.001 · Cited by 294 · cited 1×
“Increasingly, inflammation and immunotoxicity as adverse outcome pathways are recognized in the etiology of ASD (Onore et al., 2012; enstrom et al., 2010; Goines and Ashwood, 2013; Depino, 2013).”
BackgroundIn search of biomarkers for autism: scientific, social and ethical challenges
Walsh, P., Elsabbagh, M., Bolton, P., & Singh, I. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3113 · Cited by 249
Increased excretion of a lipid peroxidation biomarker in autism
Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., & Wagner, G. C. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.06.002 · Cited by 236 · cited 1×
“evidence of possible low molecular weight biomarkers for ASD is emerging (Al-Gadani et al., 2009; Pastural et al., 2009; James et al., 2004; Ratajczak, 2011; Walsh et al., 2011; Hammock et al., 2012; Austin and Shandley, 2008; Ming et al., 2005).”
BackgroundLandrigan, P. J., Lambertini, L., & Birnbaum, L. S. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104285 · Cited by 230 · cited 2×
“ASD affects 1 in 110 individuals in the US (Hu, 2013), increasing to 1 in 68 according to CDC in 20142, and 1-64 in the UK (Ratajczak, 2011); ADHD affects 14% of the 4 million children born in the US each year (landrigan et al., 2012) and learning disabilities affect up to 10% of children attending public schools (Sch…”
BackgroundPeripheral and central inflammation in autism spectrum disorders
Depino, A. M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.003 · Cited by 189
Epigenetics of early-life lead exposure and effects on brain development
Senut, M.-C., Cingolani, P., Sen, A., Kruger, A., Shaik, A., Hirsch, H., Suhr, S. T., & Ruden, D. (2012) · Epigenomics · doi:10.2217/epi.12.58 · Cited by 151
Validation and quality control of replacement alternatives - current status and future challenges
Leist, M., Hasiwa, N., Daneshian, M., & Hartung, T. (2012) · Toxicology Research · doi:10.1039/c2tx20011b · Cited by 100 · cited 2×
“the formal validation of in vitro tests (Hartung et al., 2004; Hartung, 2007a; leist et al., 2012) has established a path for providing the evidence that non-animal tests can be used without compromising patient and consumer health.”
BackgroundSelf-citationFood for Thought … Mechanistic Validation
Hartung, T. (2013) · ALTEX · doi:10.14573/altex.2013.2.119 · Cited by 93
Endocrine disruptors as a threat to neurological function
Weiss, B. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.014 · Cited by 73 · cited 1×
“Interestingly, several endocrine disruptors have been identified as DNToxicants (Masuo and Ishido, 2011; Choi et al., 2004; Weiss, 2011; Boas et al., 2009).”
BackgroundHu, V. W. (2013) · Child Development · doi:10.1111/j.1467-8624.2012.01759.x · Cited by 45
Defaux, A., Zurich, M.-G., Honegger, P., & Monnet-Tschudi, F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.053 · Cited by 40
Cited by
Adverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
Self-citationNew approach methodologies in human regulatory toxicology – Not if, but how and when!
Schmeisser, S., Miccoli, A., von Bergen, M., Berggren, E., Braeuning, A., Busch, W., Desaintes, C., Gourmelon, A., Grafström, R., Harrill, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108082 · Cited by 380
A framework for establishing scientific confidence in new approach methodologies
van der Zalm, A. J., Barroso, J., Browne, P., Casey, W., Gordon, J., Henry, T. R., Kleinstreuer, N. C., Lowit, A. B., Perron, M., & Clippinger, A. J. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03365-4 · Cited by 257
Fritsche, E., Grandjean, P., Crofton, K. M., Aschner, M., Goldberg, A., Heinonen, T., Hessel, E. V. S., Hogberg, H. T., Bennekou, S. H., Lein, P. J., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.004 · Cited by 124
Self-citationFritsche, E. (2017) · ALTEX · doi:10.14573/altex.1701171 · Cited by 118
“derlined the regulatory benefit of testing biological processes directly linked to toxicity endophenotypes based on the assumption that nervous system development is impaired when key biological processes are disturbed (Lein et al., 2005; Smirnova et al., 2014).”
Background
Metadata
- Authors
- Smirnova, L.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2014
- Volume
- 31
- Issue
- 2
- Pages
- 129-56
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2316051439
- Cited by
- 154
- References
- 26
- FWCI
- 22.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.